Preprandial repaglinide decreases exogenous insulin requirements and HbA1c levels in type 2 diabetic patients taking intensive insulin treatment

Author: Ozbek M.   Erdogan M.   Karadeniz M.   Cetinkalp S.   Ozgen A.   Saygili F.   Yilmaz C.   Tuzun M.  

Publisher: Springer Publishing Company

ISSN: 0940-5429

Source: Acta Diabetologica, Vol.43, Iss.4, 2006-12, pp. : 148-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content